Successful Management of Natalizumab-Associated Primary Central Nervous System Lymphoma through Autologous Stem Cell Transplant

Natalizumab is used as a second-line treatment for multiple sclerosis (MS). Some reports have linked natalizumab to primary central nervous system lymphoma (PCNSL), although few have described its management. A 45-year-old woman with Balo’s Concentric Sclerosis presented dizziness, vertigo accompani...

Descripción completa

Detalles Bibliográficos
Autores principales: Moineau-Vallée, Karine, Rinfret, Justine, Luu Hoai, My Hanh, St-Louis, Valérie, Berthelet, France, Létourneau-Guillon, Laurent, Lemieux-Blanchard, Émilie, Prat, Alexandre, Adam, Jean-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816184/
https://www.ncbi.nlm.nih.gov/pubmed/33704187
http://dx.doi.org/10.3390/curroncol28010022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816184/
https://www.ncbi.nlm.nih.gov/pubmed/33704187
http://dx.doi.org/10.3390/curroncol28010022

Ejemplares similares